Northwest Biotherapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.72 | $284.47 | 18.73% | 8 | $67.52B |
| FATE | Fate Therapeutics | Outperform |
7
|
$4.09 | $6.23 | 71.15% | 14 | $449.58M |
| CAPR | Capricor Therapeutics | Buy |
0
|
$5.33 | $13.50 | 237.71% | 1 | $183.46M |
| FBIO | Fortress Biotech | Buy |
11
|
$1.74 | $67.50 | 331.03% | 1 | $33.66M |
| PIRS | Pieris Pharmaceuticals | - |
9
|
$11.68 | $7.00 | -100.00% | 0 | $14.35M |
| ONTX | Onconova Therapeutics | Buy |
6
|
$0.68 | $11.50 | 929.41% | 0 | $13.75M |
| PSTV | Plus Therapeutics | Outperform |
11
|
$1.72 | $11.00 | 772.09% | 2 | $7.35M |
| CYCC | Cyclacel Pharmaceuticals | Outperform |
5
|
$2.65 | $240.00 | 6050.94% | 0 | $3.49M |